Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT05651022 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Indaptus Therapeutics, Inc |
| Last Updated on CT.gov | January 13, 2026 (Jan 13, 2026) |
As of March 2, 2026: Clinical trial NCT05651022 is currently active_not_recruiting participants. This clinical trial study for advanced solid tumors is not currently accepting new participants at 12 locations across the United States. The study is sponsored by Indaptus Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05651022 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05651022 was last updated Jan 13, 2026 (January 13, 2026). HelloStudys verifies this status automatically.